Impact of epidermal growth factor receptor (EGFR) kinase mutations, EGFR gene amplifications, and KRAS mutations on survival of pancreatic adenocarcinoma

J Lee, KT Jang, CS Ki, T Lim, YS Park… - … Journal of the …, 2007 - Wiley Online Library
… the relation or the impact of EGFR and KRAS mutations is yet to be … the frequency of EGFR
mutations and increased EGFR copy … of EGFR mutations with KRAS mutations because EGFR

Impact of KRAS and EGFR Gene Mutations on Recurrence and Survival in Patients with Surgically Resected Lung Adenocarcinomas

M Sonobe, M Kobayashi, M Ishikawa, R Kikuchi… - Annals of surgical …, 2012 - Springer
… Of these 339 patients, 180 with a completely resected lung adenocarcinoma, and whose
tumor harbored either KRAS codon 12 mutations or EGFR gene mutations within exons 18–21 …

Molecular changes of epidermal growth factor receptor (EGFR) and KRAS and their impact on the clinical outcomes in surgically resected adenocarcinoma of the lung

YT Kim, T Kim, DS Lee, SJ Park, J Park, SJ Seo… - Lung Cancer, 2008 - Elsevier
… in exon 21 which was associated with depletion of the EGFR gene, we could not clearly
demonstrate an association between EGFR mutations and EGFR gene copy number. Cappuzzo …

KRAS gene amplification in colorectal cancer and impact on response to EGFR‐targeted therapy

E Valtorta, S Misale, A Sartore‐Bianchi… - … journal of cancer, 2013 - Wiley Online Library
… of KRAS mutations but also KRAS amplification is associated with acquired resistance to
the EGFR inhibitors cetuximab or panitumumab. We reasoned that KRAS amplification may …

[HTML][HTML] Prognostic and therapeutic implications of EGFR and KRAS mutations in resected lung adenocarcinoma

JL Marks, S Broderick, Q Zhou, D Chitale, AR Li… - Journal of thoracic …, 2008 - Elsevier
… , KRAS wild-type tumors were not further classified by EGFR status, as EGFR mutations had
… Here, we sought to determine the prognostic significance of EGFR and KRAS mutations in …

[HTML][HTML] Impact of genetic profiles on the efficacy of anti-EGFR antibodies in metastatic colorectal cancer with KRAS mutation

T Kishiki, H Ohnishi, T Masaki… - Oncology …, 2014 - spandidos-publications.com
… with KRAS mutations who had been treated with anti-EGFR … to evaluate the impact of
KRAS mutation subtype, together … other EGFR downstream genes, on the efficacy of anti-EGFR

[HTML][HTML] KRAS Mutations Impact Clinical Outcome in Metastatic Non-Small Cell Lung Cancer

EA Eklund, C Wiel, H Fagman, LM Akyürek… - Cancers, 2022 - mdpi.com
… WT groups due to potentially receiving targeted therapies in the second line of treatment,
we excluded all patients with EGFR mutations and ALK fusions in the KRAS WT group from …

Clinical implications of KRAS mutations in lung cancer patients treated with tyrosine kinase inhibitors: an important role for mutations in minor clones

A Marchetti, M Milella, L Felicioni, F Cappuzzo, L Irtelli… - Neoplasia, 2009 - Elsevier
… -sequencing, we found three cases with concomitant KRAS and EGFR mutations. Because
… the presence of KRAS mutations in minor clones can overcome the effect of EGFR mutations, …

Implications for KRAS status and EGFR-targeted therapies in metastatic CRC

N Normanno, S Tejpar, F Morgillo, A De Luca… - Nature reviews Clinical …, 2009 - nature.com
mutations within KRAS can predict resistance to anti-EGFR monoclonal antibodies. Activating
mutations in KRAS, which could result in EGFR-… These mutations are almost exclusively …

[HTML][HTML] Prognostic implication of EGFR, KRAS, and TP53 gene mutations in a large cohort of Japanese patients with surgically treated lung adenocarcinoma

T Kosaka, Y Yatabe, R Onozato, H Kuwano… - Journal of Thoracic …, 2009 - Elsevier
… In this study, we focused on the prognostic implications of EGFR mutation, not the predictive
implications. Therefore we excluded the patients who received gefitinib from the current …